title: [Clinical studies on flomoxef in pregnant women with infections during the perinatal period].
abstract: Clinical efficacies of flomoxef (FMOX), which is a newly developed oxacephem antibiotic, were evaluated in 14 cases of obstetric and gynecologic infections during the perinatal period. The results were excellent in 6 cases (42.9%) and good in 8 cases (57.1%). No side effects nor abnormal clinical laboratory test results were observed in mothers or neonates. Thus, FMOX appears to be a useful antibiotic for perinatal infections.
authors.affiliation: Department of Obstetrics and Gynecology, Hokkaido University School of Medicine.
authors.forename: M
authors.initials: M
authors.lastname: Iwaki
authors.forename: S
authors.initials: S
authors.lastname: Makinoda
authors.forename: H
authors.initials: H
authors.lastname: Negishi
authors.forename: K
authors.initials: K
authors.lastname: Hanatani
authors.forename: T
authors.initials: T
authors.lastname: Tanaka
authors.forename: S
authors.initials: S
authors.lastname: Fujimoto
mesh_terms: D000328:Adult; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D002821:Chorioamnionitis / Q000188:drug therapy; D004341:Drug Evaluation; D004716:Endometritis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000382:microbiology; D011645:Puerperal Infection / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D002511:Cephalosporins; C045693:flomoxef